Syros Pharmaceuticals Inc. (SYRS) Declined -7.44% or -0.45 To Price $5.6 On Tuesday

Syros Pharmaceuticals Inc. (SYRS) declined -7.44% or -0.45 to $5.6. It is close to 96168 shares traded, which is 83.12% compare to the average total volume 115697. The market cap of SYRS is $237.63 million. The year to date change is -5.24%. The 52 week price range is from $5.17 to $13.58. Price of SYRS have changed 5.77% during last week. It have changed -14.79% over last month, -8.05% over last 3 months, -25.22% over last 6 months and -51.87% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for SYRS is 7.04. It is 25.71% above current price. The 200-day Moving Averages for SYRS is 7.90. It is 41.07% above current price. The 52-week High is 13.58. It is 142.50% from the current price. The 52-week Low is 5.17. It is -7.68% from current price.

There are some statistics of SYRS. It is has market cap $237.63 million. The share outstanding is 42.43 million. The average volume is 115697. The percent of top 15 Institution holding is 73.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of SYRS is -76.29%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of SYRS is -59.37%.


Share this post